{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:17:19Z","timestamp":1784114239853,"version":"3.55.0"},"reference-count":67,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNR"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Diindolylmethane (DIM), a major acid condensation product of Indole-3-carbinol, is known to inhibit platelet aggregation and thrombosis. The drugs with antiplatelet and antithrombotic activities are used to treat ischemic stroke.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The present study investigated the role of DIM on platelet aggregation inhibitory properties in middle cerebral artery occluded (MCAO) rats.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>DIM (12.5, 25, and 50 mg\/kg) was orally administered to MCAO rats for 3 days. Platelet aggregation, platelet cyclic adenosine monophosphate (cAMP), reactive oxygen species (ROS), hydrogen peroxide (H2O2), and serum cyclooxygenase (COX-1), thromboxane B2 (TXB2), and prostaglandin E2 (PGE2), and inflammatory markers were estimated. Further brain structural and functional recovery was evaluated by measuring cerebral blood flow, neurological deficits, brain infarction, blood-brain barrier (BBB) leakage, brain water content, and histological abnormalities.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>DIM significantly ameliorated adenosine diphosphate (ADP), collagen, thrombin, and arachidonic acid-induced platelet aggregation by inhibiting COX-1, TXB2, and PGE2 and elevating cAMP. Further, DIM also alleviated platelet-mediated oxidative stress (ROS and H2O2) and reduced the serum inflammatory markers, tumor necrosis factor-\u03b1 (TNF-\u03b1) and interleukin -6 (IL-6), and increased anti-inflammatory cytokine, IL-10, in MCAO rats<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>DIM treatment confers neuroprotection in MCAO rats by inhibition of platelet aggregation, platelet-mediated oxidative stress, and inflammation. Correspondingly, DIM improved cerebral blood flow and reduced neurological deficits, brain infarction, BBB leakage, brain water content, and histopathological abnormalities indicating the preservation of brain structural integrity. Thus, the present study provided preclinical evidence of DIM neuroprotection against ischemic stroke.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567202620666221116161128","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T05:59:17Z","timestamp":1668751157000},"page":"462-475","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Diindolylmethane Ameliorates Ischemic Stroke-Induced Brain Injury by\nPeripheral and Central Mechanisms"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4159-2463","authenticated-orcid":true,"given":"Sairam","family":"Krishnamurthy","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (IIT), Banaras Hindu University\n(IIT BHU), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2067-1410","authenticated-orcid":true,"given":"Kakarla","family":"Ramakrishna","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (IIT), Banaras Hindu University\n(IIT BHU), India"},{"name":"Department of Pharmacy, Koneru Lakshmaih Education Foundation, Vaddeswaram, Andhra Pradesh,\nIndia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil Kumar","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (IIT), Banaras Hindu University\n(IIT BHU), India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"387","volume":"24","author":"Bradlow H.L.","year":"2010","unstructured":"Bradlow H.L.; Zeligs M.A.; Diindolylmethane (DIM) spontaneously forms from indole-3-carbinol (I3C) during cell culture experiments. In vivo 2010,24(4),387-391","journal-title":"In vivo"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3390\/ijms17071155","volume":"17","author":"Kim S.","year":"2016","unstructured":"Kim S.; Cellular and molecular mechanisms of 3,3\u2032-diindolylmethane in gastrointestinal cancer. Int J Mol Sci 2016,17(7),1155","journal-title":"Int J Mol Sci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3389\/fimmu.2019.01620","volume":"10","author":"Du H.","year":"2019","unstructured":"Du H.; Zhang X.; Zeng Y.; A novel phytochemical, DIM, inhibits proliferation, migration, invasion and TNF-&#x3B1; induced inflammatory cytokine production of synovial fibroblasts from rheumatoid arthritis patients by targeting MAPK and AKT\/mTOR signal pathway. Front Immunol 2019,10,1620","journal-title":"Front Immunol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1700119","DOI":"10.1002\/mnfr.201700119","volume":"61","author":"Yang H.","year":"2017","unstructured":"Yang H.; Seo S.G.; Shin S.H.; 3,3\u2032-Diindolylmethane suppresses high-fat diet-induced obesity through inhibiting adipogenesis of pre-adipocytes by targeting USP2 activity. Mol Nutr Food Res 2017,61(10),1700119","journal-title":"Mol Nutr Food Res"},{"key":"ref=5","first-page":"727","volume":"13","author":"L&#xF3;pez-V&#xE1;zquez A.","year":"2017","unstructured":"L&#xF3;pez-V&#xE1;zquez A.; Garcia-Ba&#xF1;uelos J.J.; Gonz&#xE1;lez-Garibay A.S.; IRS-1 pY612 and Akt-1\/PKB pT308 phosphorylation and antiinflammatory effect of diindolylmethane in adipocytes cocultured with macrophages. Med Chem 2017,13(8),727-733","journal-title":"Med Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s13105-014-0332-5","volume":"70","author":"Jayakumar P.","year":"2014","unstructured":"Jayakumar P.; Pugalendi K.V.; Sankaran M.; Attenuation of hyperglycemia-mediated oxidative stress by indole-3-carbinol and its metabolite 3, 3\u2032- diindolylmethane in C57BL\/6J mice. J Physiol Biochem 2014,70(2),525-534","journal-title":"J Physiol Biochem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3390\/ijms21062048","volume":"21","author":"Munakarmi S.","year":"2020","unstructured":"Munakarmi S.; Chand L.; Shin H.B.; Jang K.Y.; Jeong Y.J.; Indole-3-carbinol derivative DIM mitigates carbon tetrachloride-induced acute liver injury in mice by inhibiting inflammatory response, apoptosis and regulating oxidative stress. Int J Mol Sci 2020,21(6),2048","journal-title":"Int J Mol Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10495-019-01522-2","volume":"24","author":"Rzemieniec J.","year":"2019","unstructured":"Rzemieniec J.; Wnuk A.; Laso\u0144 W.; Bilecki W.; Kajta M.; The neuroprotective action of 3,3\u2032-diindolylmethane against ischemia involves an inhibition of apoptosis and autophagy that depends on HDAC and AhR\/CYP1A1 but not ER&#x3B1;\/CYP19A1 signaling. Apoptosis 2019,24(5-6),435-452","journal-title":"Apoptosis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e53427","DOI":"10.1371\/journal.pone.0053427","volume":"8","author":"Zong J.","year":"2013","unstructured":"Zong J.; Deng W.; Zhou H.; 3,3\u2032-Diindolylmethane protects against cardiac hypertrophy via 5\u2032-adenosine monophosphate-activated protein kinase-&#x3B1;2. PLoS One 2013,8(1),e53427","journal-title":"PLoS One"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ptr.2260","volume":"22","author":"Park M.K.","year":"2008","unstructured":"Park M.K.; Rhee Y-H.; Lee H-J.; Antiplatelet and antithrombotic activity of indole-3-carbinol in vitro and in vivo. Phytother Res 2008,22(1),58-64","journal-title":"Phytother Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2041632","DOI":"10.1080\/14786419.2022.2041632","author":"Ramakrishna K.","year":"2022","unstructured":"Ramakrishna K.; Krishnamurthy S.; Indole-3-carbinol ameliorated the isoproterenol-induced myocardial infarction via multimodal mechanisms in Wistar rats. Nat Prod Res 2022,2041632","journal-title":"Nat Prod Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"174812","DOI":"10.1016\/j.ejphar.2022.174812","volume":"919","author":"Ramakrishna K.","year":"2022","unstructured":"Ramakrishna K.; Singh N.; Krishnamurthy S.; Diindolylmethane ameliorates platelet aggregation and thrombosis: In silico, in vitro, and in vivo studies. Eur J Pharmacol 2022,919,174812","journal-title":"Eur J Pharmacol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00210-018-1488-2","volume":"391","author":"Paliwal P.","year":"2018","unstructured":"Paliwal P.; Chauhan G.; Gautam D.; Dash D.; Patne S.C.U.; Krishnamurthy S.; Indole-3-carbinol improves neurobehavioral symptoms in a cerebral ischemic stroke model. Naunyn Schmiedebergs Arch Pharmacol 2018,391(6),613-625","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s13318-022-00771-y","volume":"47","author":"Ramakrishna K.","year":"2022","unstructured":"Ramakrishna K.; Jain S.K.; Krishnamurthy S.; Pharmacokinetic and pharmacodynamic properties of indole-3-carbinol in experimental focal ischemic injury. Eur J Drug Metab Pharmacokinet 2022,47(4),593-605","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1871527321666220418120224","DOI":"10.2174\/1871527321666220418120224","volume":"21","author":"Dhir N.","year":"2022","unstructured":"Dhir N.; Jain A.; Sharma A.R.; Prakash A.; Bhatia A.; Medhi B.; Neuroprotective effect of 3,3\u2032-diindolylmethane and \u0251-naphthoflavone, aryl hydrocarbon receptor modulators in an experimental model of ischemic stroke. CNS Neurol Disord Drug Targets 2022,21,1871527321666220418120224","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.107.691279","volume":"115","author":"Kleinschnitz C.","year":"2007","unstructured":"Kleinschnitz C.; Pozgajova M.; Pham M.; Bendszus M.; Nieswandt B.; Stoll G.; Targeting platelets in acute experimental stroke: Impact of glycoprotein Ib, VI, and IIb\/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation 2007,115(17),2323-2330","journal-title":"Circulation"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.3389\/fimmu.2019.02505","volume":"10","author":"Stegner D.","year":"2019","unstructured":"Stegner D.; Klaus V.; Nieswandt B.; Platelets as modulators of cerebral ischemia\/reperfusion injury. Front Immunol 2019,10,2505","journal-title":"Front Immunol"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","volume":"20","author":"Longa E.Z.","year":"1989","unstructured":"Longa E.Z.; Weinstein P.R.; Carlson S.; Cummins R.; Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989,20(1),84-91","journal-title":"Stroke"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"188","DOI":"10.25259\/IJPP_172_2020","volume":"64","author":"Ramakrishna K.","year":"2021","unstructured":"Ramakrishna K.; Srinivasan K.; Sharma S.S.; Chronic treatment of 4-phenylbutyric acid ameliorates cognitive impairment after focal cerebral ischemia\/reperfusion injury in rats. Indian J Physiol Pharmacol 2021,64(3),188-194","journal-title":"Indian J Physiol Pharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"106088","DOI":"10.22541\/au.159248857.72994533","volume":"2022","author":"Irfan M.","year":"2022","unstructured":"Irfan M.; Kwon T-H.; Kwon H-W.; Rhee M.H.; Pharmacological actions of Dieckol on the modulation of platelet functions and thrombus formation via integrin &#x3B1;IIb&#x3B2;3 and cAMP signaling. Pharmacol Res 2022,2022,106088","journal-title":"Pharmacol Res"},{"key":"ref=21","first-page":"1934578X20910863","volume":"15","author":"Li X","year":"2020","unstructured":"Li X; Wang J-W; Huang B; Peng Z-X; Zhang Y-Y; Zhao S-Y; Synthesis of 3, 15-disuccinate-12-coumarin substituted andrographolide derivatives and their antiplatelet aggregation activities in vitro. Nat Prod Commun 2020,15(5),1934578X20910863","journal-title":"Nat Prod Commun"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"153330","DOI":"10.1016\/j.phymed.2020.153330","volume":"79","author":"Cheng T.F.","year":"2020","unstructured":"Cheng T.F.; Zhao J.; Wu Q.L.; Compound Dan Zhi tablet attenuates experimental ischemic stroke via inhibiting platelet activation and thrombus formation. Phytomedicine 2020,79,153330","journal-title":"Phytomedicine"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/jcbfm.2009.185","volume":"30","author":"Guo Q.","year":"2010","unstructured":"Guo Q.; Wang G.; Namura S.; Fenofibrate improves cerebral blood flow after middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 2010,30(1),70-78","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.bcp.2018.07.028","volume":"155","author":"Mishra A.","year":"2018","unstructured":"Mishra A.; Chandravanshi L.P.; Trigun S.K.; Krishnamurthy S.; Ambroxol modulates 6-Hydroxydopamine-induced temporal reduction in Glucocerebrosidase (GCase) enzymatic activity and Parkinson\u2019s disease symptoms. Biochem Pharmacol 2018,155,479-493","journal-title":"Biochem Pharmacol"},{"key":"ref=25","first-page":"233","volume":"1","author":"Meyer O.A.","year":"1979","unstructured":"Meyer O.A.; Tilson H.A.; Byrd W.C.; Riley M.T.; A method for the routine assessment of fore and hindlimb grip strength of rats and mice. Neurobehav Toxicol 1979,1(3),233-236","journal-title":"Neurobehav Toxicol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fphar.2019.00297","volume":"10","author":"Shah F.A.","year":"2019","unstructured":"Shah F.A.; Liu G.; Al Kury L.T.; Melatonin protects MCAO-induced neuronal loss via NR2A mediated prosurvival pathways. Front Pharmacol 2019,10,297","journal-title":"Front Pharmacol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nbd.2016.02.020","volume":"91","author":"Zhang W.","year":"2016","unstructured":"Zhang W.; Zhang H.; Mu H.; Omega-3 polyunsaturated fatty acids mitigate blood\u2013brain barrier disruption after hypoxic\u2013ischemic brain injury. Neurobiol Dis 2016,91,37-46","journal-title":"Neurobiol Dis"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jchemneu.2017.04.008","volume":"87","author":"Maleki S.N.","year":"2018","unstructured":"Maleki S.N.; Aboutaleb N.; Souri F.; Berberine confers neuroprotection in coping with focal cerebral ischemia by targeting inflammatory cytokines. J Chem Neuroanat 2018,87,54-59","journal-title":"J Chem Neuroanat"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0049-3848(95)93881-Y","volume":"77","author":"Bednar B.","year":"1995","unstructured":"Bednar B.; Condra C.; Gould R.J.; Connolly T.M.; Platelet aggregation monitored in a 96 well microplate reader is useful for evaluation of platelet agonists and antagonists. Thromb Res 1995,77(5),453-463","journal-title":"Thromb Res"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jgr.2020.04.001","volume":"2021","author":"Kim E.S.","year":"2021","unstructured":"Kim E.S.; Lee J-S.; Lee H.G.; Improvement of antithrombotic activity of red ginseng extract by nanoencapsulation using chitosan and antithrombotic cross-linkers: Polyglutamic acid and fucodian. J Ginseng Res 2021,2021,236-245","journal-title":"J Ginseng Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jff.2019.02.015","volume":"54","author":"Liu C.","year":"2019","unstructured":"Liu C.; Guo H.; DaSilva N.A.; Pomegranate (Punica granatum) phenolics ameliorate hydrogen peroxide-induced oxidative stress and cytotoxicity in human keratinocytes. J Funct Foods 2019,54,559-567","journal-title":"J Funct Foods"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"79247","DOI":"10.18632\/oncotarget.13018","volume":"7","author":"Pan S.","year":"2016","unstructured":"Pan S.; Li S.; Hu Y.; Resveratrol post-treatment protects against neonatal brain injury after hypoxia-ischemia. Oncotarget 2016,7(48),79247-79261","journal-title":"Oncotarget"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"924","DOI":"10.14336\/AD.2017.1126","volume":"9","author":"Liu F.","year":"2018","unstructured":"Liu F.; Lu J.; Manaenko A.; Tang J.; Hu Q.; Mitochondria in ischemic stroke: New insight and implications. Aging Dis 2018,9(5),924-937","journal-title":"Aging Dis"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1161\/STROKEAHA.108.541128","volume":"40","author":"Fisher M.","year":"2009","unstructured":"Fisher M.; Feuerstein G.; Howells D.W.; Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009,40(6),2244-2250","journal-title":"Stroke"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1161\/01.STR.30.12.2752","volume":"30","year":"1999","unstructured":"Stair. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999,30(12),2752-2758","journal-title":"Stroke"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"C343","DOI":"10.1152\/ajpcell.00095.2018","volume":"315","author":"Abdullahi W.","year":"2018","unstructured":"Abdullahi W.; Tripathi D.; Ronaldson P.T.; Blood-brain barrier dysfunction in ischemic stroke: Targeting tight junctions and transporters for vascular protection. Am J Physiol Cell Physiol 2018,315(3),C343-C356","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1742-2094-11-107","volume":"11","author":"Liu T.","year":"2014","unstructured":"Liu T.; Zhang T.; Yu H.; Shen H.; Xia W.; Adjudin protects against cerebral ischemia reperfusion injury by inhibition of neuroinflammation and blood-brain barrier disruption. J Neuroinflammat 2014,11(1),107","journal-title":"J Neuroinflammat"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1002\/cpim.83","volume":"126","author":"Goldim M.P.S.","year":"2019","unstructured":"Goldim M.P.S.; Della Giustina A.; Petronilho F.; Using evans blue dye to determine blood\u2010brain barrier integrity in rodents. Curr Protoc Immunol 2019,126(1),e83","journal-title":"Curr Protoc Immunol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1161\/STROKEAHA.108.514927","volume":"39","author":"Jin G.","year":"2008","unstructured":"Jin G.; Arai K.; Murata Y.; Protecting against cerebrovascular injury: Contributions of 12\/15-lipoxygenase to edema formation after transient focal ischemia. Stroke 2008,39(9),2538-2543","journal-title":"Stroke"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.nbd.2008.08.005","volume":"32","author":"Sandoval K.E.","year":"2008","unstructured":"Sandoval K.E.; Witt K.A.; Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 2008,32(2),200-219","journal-title":"Neurobiol Dis"},{"key":"ref=41","author":"Ioannides K.","year":"2017","unstructured":"Ioannides K.; Tadi P.; Naqvi I.A.;  Cerebellar Infarct 2017","journal-title":"Cerebellar Infarct"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbr.2011.07.004","volume":"225","author":"Srinivasan K.","year":"2011","unstructured":"Srinivasan K.; Sharma S.S.; Sodium phenylbutyrate ameliorates focal cerebral ischemic\/reperfusion injury associated with comorbid type 2 diabetes by reducing endoplasmic reticulum stress and DNA fragmentation. Behav Brain Res 2011,225(1),110-116","journal-title":"Behav Brain Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/09537104.2019.1585526","volume":"31","author":"Onselaer M.B.","year":"2020","unstructured":"Onselaer M.B.; Nagy M.; Pallini C.; Comparison of the GPVI inhibitors losartan and honokiol. Platelets 2020,31(2),187-197","journal-title":"Platelets"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10557-019-06930-9","volume":"34","author":"Li X.","year":"2020","unstructured":"Li X.; Liu P.; Xu Z.; A pharmacodynamic study of CN-218, a novel antiplatelet and antithrombotic agent primarily targeting the P2Y12 receptor. Cardiovasc Drugs Ther 2020,34(1),15-23","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.thromres.2013.03.005","volume":"132","author":"Sakata C.","year":"2013","unstructured":"Sakata C.; Kawasaki T.; Kato Y.; ASP6537, a novel highly selective cyclooxygenase-1 inhibitor, exerts potent antithrombotic effect without &#x201C;aspirin dilemma&#x201D;. Thromb Res 2013,132(1),56-62","journal-title":"Thromb Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13020-021-00424-3","volume":"16","author":"Xu Z.","year":"2021","unstructured":"Xu Z.; Xu Y.; Xie X.; Anti-platelet aggregation of Panax notoginseng triol saponins by regulating GP1BA for ischemic stroke therapy. Chin Med 2021,16(1),12","journal-title":"Chin Med"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jgr.2020.11.001","volume":"45","author":"Shin J-H.","year":"2021","unstructured":"Shin J-H.; Kwon H-W.; Irfan M.; Rhee M.H.; Lee D-H.; Ginsenoside Rk1 suppresses platelet mediated thrombus formation by downregulation of granule release and &#x3B1;IIb&#x3B2;3 activation. J Ginseng Res 2021,45(4),490-497","journal-title":"J Ginseng Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1538-7836.2009.03370.x","volume":"7","author":"Nieswandt B.","year":"2009","unstructured":"Nieswandt B.; Varga-Szabo D.; Elvers M.; Integrins in platelet activation. J Thromb Haemost 2009,7(Suppl. 1),206-209","journal-title":"J Thromb Haemost"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13045-019-0709-6","volume":"12","author":"Huang J.","year":"2019","unstructured":"Huang J.; Li X.; Shi X.; Platelet integrin &#x3B1;IIb&#x3B2;3: signal transduction, regulation, and its therapeutic targeting. J Hematol Oncol 2019,12(1),26","journal-title":"J Hematol Oncol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0049-3848(02)00395-X","volume":"108","author":"Seiffert D.","year":"2002","unstructured":"Seiffert D.; Pedicord D.L.; Kieras C.J.; He B.; Stern A.M.; Billheimer J.T.; Regulation of clot retraction by glycoprotein IIb\/IIIa antagonists. Thromb Res 2002,108(2-3),181-189","journal-title":"Thromb Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3109\/09537104.2010.497231","volume":"22","author":"Kim S.","year":"2011","unstructured":"Kim S.; Kunapuli S.P.; P2Y12 receptor in platelet activation. Platelets 2011,22(1),54-58","journal-title":"Platelets"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1172\/JCI20986","volume":"113","author":"Dorsam R.T.","year":"2004","unstructured":"Dorsam R.T.; Kunapuli S.P.; Central role of the P2Y12 receptor in platelet activation. J Clin Invest 2004,113(3),340-345","journal-title":"J Clin Invest"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.redox.2017.08.021","volume":"14","author":"Qiao J.","year":"2018","unstructured":"Qiao J.; Arthur J.F.; Gardiner E.E.; Andrews R.K.; Zeng L.; Xu K.; Regulation of platelet activation and thrombus formation by reactive oxygen species. Redox Biol 2018,14,126-130","journal-title":"Redox Biol"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1515\/tnsci-2021-0006","volume":"12","author":"Fu K.","year":"2021","unstructured":"Fu K.; Chen M.; Zheng H.; Li C.; Yang F.; Niu Q.; Pelargonidin ameliorates MCAO-induced cerebral ischemia\/reperfusion injury in rats by the action on the Nrf2\/HO-1 pathway. Transl Neurosci 2021,12(1),20-31","journal-title":"Transl Neurosci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1089\/ars.2013.5337","volume":"20","author":"Jang J.Y.","year":"2014","unstructured":"Jang J.Y.; Min J.H.; Chae Y.H.; Reactive oxygen species play a critical role in collagen-induced platelet activation via SHP-2 oxidation. Antioxid Redox Signal 2014,20(16),2528-2540","journal-title":"Antioxid Redox Signal"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1113\/jphysiol.2011.225417","volume":"590","author":"Stokes K.Y.","year":"2012","unstructured":"Stokes K.Y.; Granger D.N.; Platelets: A critical link between inflammation and microvascular dysfunction. J Physiol 2012,590(5),1023-1034","journal-title":"J Physiol"},{"key":"ref=57","first-page":"256","volume":"255","author":"Rabinovici R.","year":"1990","unstructured":"Rabinovici R.; Yue T.L.; Farhat M.; Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: Studies with BN 50739, a novel PAF antagonist. J Pharmacol Exp Ther 1990,255(1),256-263","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1182\/blood-2005-03-1247","volume":"106","author":"Pignatelli P.","year":"2005","unstructured":"Pignatelli P.; De Biase L.; Lenti L.; Tumor necrosis factor-&#x3B1; as trigger of platelet activation in patients with heart failure. Blood 2005,106(6),1992-1994","journal-title":"Blood"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1182\/blood.V83.2.398.398","volume":"83","author":"Peng J.","year":"1994","unstructured":"Peng J.; Friese P.; George J.N.; Dale G.L.; Burstein S.A.; Alteration of platelet function in dogs mediated by interleukin-6. Blood 1994,83(2),398-403","journal-title":"Blood"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1172\/JCI30639","volume":"117","author":"Mutlu G.M.","year":"2007","unstructured":"Mutlu G.M.; Green D.; Bellmeyer A.; Ambient particulate matter accelerates coagulation via an IL-6\u2013dependent pathway. J Clin Invest 2007,117(10),2952-2961","journal-title":"J Clin Invest"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"828447","DOI":"10.3389\/fimmu.2022.828447","volume":"13","author":"Zhu H.","year":"2022","unstructured":"Zhu H.; Hu S.; Li Y.; Interleukins and Ischemic Stroke. Front Immunol 2022,13,828447","journal-title":"Front Immunol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/toxsci\/kft240","volume":"137","author":"Kim H.W.","year":"2014","unstructured":"Kim H.W.; Kim J.; Kim J.; 3,3\u2032-Diindolylmethane inhibits lipopolysaccharide-induced microglial hyperactivation and attenuates brain inflammation. Toxicol Sci 2014,137(1),158-167","journal-title":"Toxicol Sci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40360-018-0262-x","volume":"19","author":"Luo Q.","year":"2018","unstructured":"Luo Q.; Yang A.; Cao Q.; Guan H.; 3,3\u2032-Diindolylmethane protects cardiomyocytes from LPS-induced inflammatory response and apoptosis. BMC Pharmacol Toxicol 2018,19(1),71","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"Powers W.J.","year":"2019","unstructured":"Powers W.J.; Rabinstein A.A.; Ackerson T.; Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 2019,50(12),e344-e418","journal-title":"Stroke"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jacc.2019.06.039","volume":"74","author":"Del Brutto V.J.","year":"2019","unstructured":"Del Brutto V.J.; Chaturvedi S.; Diener H.C.; Romano J.G.; Sacco R.L.; Antithrombotic therapy to prevent recurrent strokes in ischemic cerebrovascular disease: JACC scientific expert panel. J Am Coll Cardiol 2019,74(6),786-803","journal-title":"J Am Coll Cardiol"},{"key":"ref=66","author":"Chang R.C-C.","year":"2019","unstructured":"Chang R.C-C.; Ho Y-S.; Introductory Chapter: Concept of Neuroprotection-A New Perspective. In: Neuroprotection 2019","journal-title":"Neuroprotection"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40256-013-0007-6","volume":"13","author":"Bansal S.","year":"2013","unstructured":"Bansal S.; Sangha K.S.; Khatri P.; Drug treatment of acute ischemic stroke. Am J Cardiovasc Drugs 2013,13(1),57-69","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["Current Neurovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567202620666221116161128","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/210981\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567202620666221116161128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T13:05:42Z","timestamp":1674738342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/210981\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567202620666221116161128","relation":{},"ISSN":["1567-2026"],"issn-type":[{"value":"1567-2026","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-09-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}